Life Sciences Advanced Technologies, Inc was founded 40 years ago and the first company in the world which manufacture AMV RT. AMV RT is later used in NASBA, RT-PCR, LAMP, for research and development of many infecious diseases worldwide, such as HIV, HPV, Hepatitis, Pneumonia, Dengue virus, Zika virus, common flu virus etc.

As a world leader of reagents for research and development of infectious diseases, we are proud of our  NASBA enzyme. On this page, we selected a list of scientific publications in top international journals by our top scientists or scientists who bought our AMV RT enzymes and NASBA acusphere for their research and development:

LSAT booth in BioFlorida 2016

General Manager of Life Sciences Advanced Technologies Inc, Fred Perez, Chief Technologies Officer, Dr. Zhan Zhang, briefed Congressman Ted Yoho about the edge Life Sciences Advanced Technologies Inc. has on research and development of infectious diseases.

                                                                            

Recent Scientific Publications

J Virol. 1978 Feb;25(2):546-52. Protein kinase from avian myeloblastosis virus. Houts GE, Miyagi M, Ellis C, Beard D, Watson KF, Beard JW. https://www.ncbi.nlm.nih.gov/pubmed/24125

J Virol. 1979 Feb;29(2):517-22. Reverse transcriptase from avian myeloblastosis virus. Houts GE, Miyagi M, Ellis C, Beard D, Beard JW.  https://www.ncbi.nlm.nih.gov/pubmed/85721

Enhancing the Value of Molecular Methods to the Water Industry: An E. coli Case Study. Water Research Foundation http://www.waterrf.org/Pages/Projects.aspx?PID=4238

Rapid, Low-Cost Detection of Zika Virus Using Programmable Biomolecular Components. Keith Pardee, Alexander A. Green, Melissa K. Takahashi, …,David H. O’Connor, Lee Gehrke,James J. Collins.
http://www.cell.com/pb-assets/journals/research/cell/cell8923.pdf